Lans Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Lans Pharma Llp

Lans Pharma Llp, a active limited liability partnership, was established on 27 May 2016 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAG-4866. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.20 M.

Its leadership includes Lalitkumar Narottamdas Shah (Designated Partner), Namit Lalit Shah (Designated Partner), Ankit Lalit Shah (Designated Partner). Past directors included Jyoti Lalit Shah. Its latest date of accounts and solvency statement 31 March 2025. It is based at 1306 Shubham Avenue ,Building No.19/21, Pant Nagar,Shri Gurudutt Mandir Marg ,Ghatkopar,East, Mumbai, Maharashtra, 400075.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAG-4866

  • Incorporation Date

    27 May 2016

  • Total Obligation of Contribution

    ₹0.20 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.20 M
  • Company Age 9 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Lans Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Lans Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lans Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Lalitkumar Narottamdas Shah Designated Partner 27 May 2016 Current
Namit Lalit Shah Designated Partner 29 Jan 2024 Current
Ankit Lalit Shah Designated Partner 29 Jan 2024 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 29 Jan 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lans Pharma Llp.

Enhance accessibility to Lans Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Lans Pharma Llp revenue growth over time
Lans Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lans Pharma Llp?

Unlock access to Lans Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lans Pharma Llp?

Unlock and access historical data on people associated with Lans Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lans Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lans Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lans Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Lans Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Lans Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Namit Lalit Shah was appointed as a Designated Partner was appointed as a Designated Partner on 29 Jan 2024 & has been associated with this company since 2 years 2 months . was recorded as a recent event.

  • Director Appointment

    Ankit Lalit Shah was appointed as a Designated Partner was appointed as a Designated Partner on 29 Jan 2024 & has been associated with this company since 2 years 2 months . was recorded as a recent event.

  • Director Appointment

    Lalitkumar Narottamdas Shah was appointed as a Designated Partner was appointed as a Designated Partner on 27 May 2016 & has been associated with this company since 9 years 11 months . was recorded as a recent event.

  • LLP Incorporation

    Progress on Lans Pharma Llp was registered on 27 May 2016 with Roc Mumbai & aged 9 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Lans Pharma Llp?

The LLPIN of Lans Pharma Llp is AAG-4866.

Where is Lans Pharma Llp headquartered?

Lans Pharma Llp is headquartered at 1306 Shubham Avenue ,Building No.19/21, Pant Nagar,Shri Gurudutt Mandir Marg ,Ghatkopar,East, Mumbai, Maharashtra, 400075.

When was Lans Pharma Llp incorporated?

Lans Pharma Llp was incorporated on 27 May 2016.

Who are the current directors of Lans Pharma Llp?

The current directors of Lans Pharma Llp are

What is the primary industry of Lans Pharma Llp?

The primary industry of Lans Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available